Bicycle Therapeutics Plc (BCYC)
4.55
+0.10
(+2.25%)
USD |
NASDAQ |
May 22, 16:00
4.55
0.00 (0.00%)
After-Hours: 20:00
Bicycle Therapeutics EPS Diluted (Quarterly) : -0.8714 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Biodexa Pharmaceuticals Plc | -- |
| Mereo BioPharma Group Plc | -0.0418 |
| NuCana Plc | -1.28 |
| Autolus Therapeutics Plc | -0.2686 |
| Cellectis SA | -0.1774 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -60.72M |
| Revenue (Quarterly) | 0.8855M |
| Total Expenses (Quarterly) | 61.61M |
| Enterprise Value | -226.44M |
| Gross Profit Margin (Quarterly) | -27.28% |
| Profit Margin (Quarterly) | -6.86K% |
| Earnings Yield | -69.52% |
| Normalized Earnings Yield | -69.52 |